Research News

DriverDetect Software: Enhancing Cancer Mutation Prediction with Machine Learning

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof Chen Ee Sin co-led the study on DriverDetect, a machine learning algorithm (developed in NUS) that combines outputs from seven tools to better predict driver mutations. Trained on cancer-specific mutation datasets, it outperformed individual tools in validation tests. DriverDetect can integrate new prediction algorithms and be retrained with new data, making it suitable for broad cancer analysis and cross-cancer studies.

Click here to read more.

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera

Muscle is our first line of defence against cancer. A randomised clinical trial in Singapore, led by N2CR members A/Prof …

Read More →
Research News

Efficacy of Combined Pembrolizumab and Bevacizumab in Platinum-Resistant Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is common in South China and parts of Southeast Asia. Despite treatment, 20-30% of patients relapse within …

Read More →
Research News

Cell Cycle Dysregulation in Cancer

A study led by Dr Alan Prem Kumar, a member of N2CR, delves into how cancer arises from disruptions in …

Read More →